Robert Charles Swanton serves as Executive at BICYCLE THERAPEUTICS PLC, where they oversee executive responsibilities. Since joining the company, Robert Charles Swanton has executed 2 insider transactions totaling $872, demonstrating a bearish approach to their equity position. Their most recent transaction on Oct 2, 2025 involved selling 102 shares valued at $872.
Robert Charles Swanton currently holds 15,487 shares of BICYCLE THERAPEUTICS PLC (BCYC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Charles Swanton has been a net seller of BCYC stock. They have purchased $0 and sold $872 worth of shares.
Robert Charles Swanton's most recent insider trade was on Oct 2, 2025, when they sold 102 shares at $8.55 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |